Recent Advances in Mass Spectrometry-Based Studies of Post-Translational Modifications in Alzheimer’s Disease
Molecular & Cellular Proteomics · 2025
DOI: 10.1016/j.mcpro.2025.101003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular & Cellular Proteomics, 2025. Verfasst von Feixuan Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Protein Processing, Post-Translational, Mass Spectrometry. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 203 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, American Society for Mass Spectrometry, National Institute of Diabetes and Digestive and Kidney Diseases.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline. There are more than 10 million new cases of AD each year worldwide, implying one new case every 3.2 s. Post-translational modifications (PTMs) such as phosphorylation, glycosylation, and citrullination have emerged as key modulators of protein function in AD, influencing protein aggregation, clearance, and toxicity. Mass spectrometry (MS) has become an indispensable tool for detecting and quantifying these PTMs, offering valuable insights into their role in AD pathogenesis. This review explores recent advancements in MS-based studies of PTMs in AD, with emphasis on MS techniques, such as data-dependent acquisition (DDA) and data-independent acquisition (DIA), as well as enrichment methods used to characterize PTMs. The applications of these MS-based approaches to the study of various PTMs are highlighted, which have significantly accelerated the biomarker discovery process, providing new avenues for early diagnosis and therapeutic targeting. Advances in biological understanding and analytical techniques, while addressing the challenges and future directions, will be discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, USA; Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA; Biophysics Graduate Program, University of Wisconsin-Madis…
Förderung
- NIGMS NIH HHS
- American Society for Mass Spectrometry
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health Office of the Director
- NIH National Institute of General Medical Sciences
- National Institutes of Health
- National Institute on Aging
- University of Wisconsin-Madison
Zitieren
APA
Wu, F., Li, W., Lu, H., & Li, L. (2025). Recent Advances in Mass Spectrometry-Based Studies of Post-Translational Modifications in Alzheimer’s Disease. Molecular & Cellular Proteomics. https://doi.org/10.1016/j.mcpro.2025.101003
Vancouver
Wu F, Li W, Lu H, Li L. Recent Advances in Mass Spectrometry-Based Studies of Post-Translational Modifications in Alzheimer’s Disease. Molecular & Cellular Proteomics. 2025. doi:10.1016/j.mcpro.2025.101003
BibTeX
@article{Wu2025,
author = {Wu, Feixuan and Li, Wei and Lu, Haiyan and Li, Lingjun},
title = {Recent Advances in Mass Spectrometry-Based Studies of Post-Translational Modifications in Alzheimer’s Disease},
journal = {Molecular & Cellular Proteomics},
year = {2025},
doi = {10.1016/j.mcpro.2025.101003}
}
EUVIMED